Akso Health Group Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount
Akso Health Group (AHG) had Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount of $30.79 million as of 2022-09-30, per its 6-K filed 2023-02-16.
Discontinued › Notes › Debt and Equity Securities
us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount · last filed 2023-02-16
- 2022-09-30: Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount $30.79M.
- 2022-03-31: Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount $30.79M.
- 2021-03-31: Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount $30.79M.
- 2020-03-31: Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount $29.19M.
| Period end | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount |
|---|---|
| 2022-09-30 | $30.79M 6-K · filed 2023-02-16 |
| 2022-03-31 | $30.79M 6-K · filed 2023-02-16 |
| 2021-03-31 | $30.79M 20-F · filed 2022-12-29 |
| 2020-03-31 | $29.19M 20-F · filed 2021-07-28 |